Docking scores do not establish binding affinity or therapeutic efficacy: concerns regarding the interpretation of in silico findings on TTK inhibition in lung adenocarcinoma

This Matters Arising commentary addresses the recent article by Patidar et al. ( 2026 ) on TTK-mediated ceRNA networks in lung adenocarcinoma. We identify two critical scientific issues that are not addressed in the original paper’s Limitations section. First, the authors interpret molecular docking scores as evidence of binding affinity and inhibitory activity, which is scientifically unsupported. Second, the therapeutic recommendation for hesperidin lacks any functional validation, as no enzymatic, cellular, or in vivo assays were performed. These concerns fundamentally affect the validity of the paper’s therapeutic conclusions and warrant clarification.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Research and Clinical Oncology
Published
2026-11-19
DOI
https://doi.org/10.1007/s00432-026-06657-9
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Docking scores do not establish binding affinity or therapeutic efficacy: concerns regarding the interpretation of in silico findings on TTK inhibition in lung adenocarcinoma

Ehsan Khodamoradi
Journal of Cancer Research and Clinical Oncology
Computational Drug Discovery Methods
article

Docking scores do not establish binding affinity or therapeutic efficacy: concerns regarding the interpretation of in silico findings on TTK inhibition in lung adenocarcinoma

Ehsan Khodamoradi
article en

Abstract

This Matters Arising commentary addresses the recent article by Patidar et al. ( 2026 ) on TTK-mediated ceRNA networks in lung adenocarcinoma. We identify two critical scientific issues that are not addressed in the original paper’s Limitations section. First, the authors interpret molecular docking scores as evidence of binding affinity and inhibitory activity, which is scientifically unsupported. Second, the therapeutic recommendation for hesperidin lacks any functional validation, as no enzymatic, cellular, or in vivo assays were performed. These concerns fundamentally affect the validity of the paper’s therapeutic conclusions and warrant clarification.

Journal of Cancer Research and Clinical OncologyVol. 152(12)
Kermanshah University of Medical Sciences (IR)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon